Logo-jnp
J Nephropathol. 2019;8(3): e25. doi: 10.15171/jnp.2019.25

Original Article

Efficacy and safety of a modified- ‘modified Ponticelli’ regimen for treatment of primary membranous nephropathy

Indu Ramachandra Rao 1 ORCID, Ravindra Prabhu Attur 1 ORCID, Dharshan Rangaswamy 1 ORCID, Srinivas Shenoy 1 ORCID, Sindhura Lakshmi Koulmane Laxminarayana 2 ORCID, Shankar Prasad Nagaraju 1 * ORCID

Cited by CrossRef: 3

1- George J, Jacob R. Optimizing Immunosuppression in Glomerular Diseases. 2024;2(1):28 [Crossref]
2- Choi H, Cho Y, Lee M, Yun J, Lee H, Park I. Economic Evaluation of Rituximab Versus Corticosteroid‐Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea. Nephrology. 2025;30(6) [Crossref]
3- Vaidyanathan A, Trivedi M, Ukirde V, Karnik N. Transfemoral thrombolysis with thrombosuction: an aid to renal biopsy in a case of acute Budd Chiari syndrome complicating nephrotic syndrome. BMJ Case Rep. 2020;13(12):e237285 [Crossref]
4- Cyclophosphamide/methylprednisolone/prednisolone. Reactions Weekly. 2019;1776(1):146 [Crossref]